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Aims The objective assessment of maximal exercise capacity (MEC) using peak oxygen consumption (VO2) measurement
may be helpful in the management of asymptomatic aortic stenosis (AS) patients. However, the relationship between
left ventricular (LV) function and MEC has been relatively unexplored. We aimed to identify which echocardiographic
parameters of LV systolic function can predict MEC in asymptomatic AS.
Methods
and results
Asymptomatic patients with moderate to severe AS (n ¼ 44, aortic valve area ,1.5 cm2, 66+ 13 years, 75% of men)
and preserved LV ejection fraction (LVEF. 50%) were prospectively referred for resting echocardiography and car-
diopulmonary exercise test. LV longitudinal strain (LS) of each myocardial segment was measured by speckle tracking
echocardiography (STE) from the apical (aLS) 4-, 2-, and 3-chamber views. An average value of the LS of the analysable
segments was provided for each myocardial region: basal (bLS), mid (mLS), and aLS. LV circumferential and radial strains
were measured from short-axis views. Peak VO2 was 20.1+ 5.8 mL/kg/min (median 20.7 mL/kg/min; range 7.2–
32.3 mL/kg/min). According to the median of peak VO2, patients with reduced MEC were significantly older
(P, 0.001) and more frequently females (P ¼ 0.05). There were significant correlations between peak VO2 and age
(r ¼ 20.44), LV end-diastolic volume (r ¼ 0.35), LV stroke volume (r ¼ 0.37), indexed stroke volume (r ¼ 0.32), and
E/e′ ratio (r ¼ 20.37, all P, 0.04). Parameters of AS severity and LVEF did not correlate with peak VO2 (P ¼ NS for
all). Among LV deformation parameters, bLS and mLS were significantly associated with peakVO2 (r ¼ 0.43, P ¼ 0.005,
and r ¼ 0.32, P ¼ 0.04, respectively). With multivariable analysis, female gender (b ¼ 4.9; P ¼ 0.008) and bLS
(b ¼ 0.50; P ¼ 0.03) were the only independent determinants (r2 ¼ 0.423) of peak VO2.
Conclusion In asymptomatic AS, impaired LV myocardial longitudinal function determines reduced MEC. Basal LS was the only
parameter of LV regional function independently associated with MEC.
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Introduction
Aortic stenosis (AS) is the most frequent type of valvular heart
disease in Europe and North America.1,2 However, there is still on-
going debate regarding the best timing for surgery in asymptomatic
patients with preserved left ventricular (LV) ejection fraction.3,4 An
assiduous search for parameters that may identify patients who may
benefit from early surgery has begun in recent years. Current guide-
lines recommend surgery in symptomatic patients with severe AS
and in those with LV ejection fraction (LVEF) ,50%.1,2 However,
the post-operative outcome of these patients seems worse than
in those operated on without symptoms or LV dysfunction.5
Clinicians are nevertheless reluctant to systematically perform
aortic valve replacement in asymptomatic patient with severe AS
and preserved LVEF (i.e. .50%), because of the combined risk of
aortic valve surgery and late complications of aortic valve prosthesis.
Hence, there is a profound need to validate parameters that may
help stratify the risk of asymptomatic patients with severe AS (i.e.
to select patient who may benefit the most from early surgery)
and that may be able to identify subclinical LV dysfunction. There
is irrefutable evidence that LVEF is a poor estimator of myocardial
contractility in patients with AS.6 – 8 LV hypertrophy or concentric
remodelling, through a simple geometric effect, can boost LVEF va-
lues creating a false impression of normal LV systolic performance.
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Consequently, attention has moved from LVEF measurement to
analysis of LV longitudinal systolic function.6 – 8 Several studies
have shown that global longitudinal strain (GLS), as assessed by
speckle tracking echocardiography (STE), is an independent predict-
or of outcome in AS.9 –11 Cardiopulmonary exercise testing (CPET)
with measurement of gas exchange provides quantitative, objective,
and more accurate non-invasive evaluation of maximal exercise cap-
acity (MEC).12 However, very few studies have focused on evaluat-
ing MEC in AS.13,14 In the present study, we sought to examine the
relationship between indices of LV function using conventional and
STE-derived parameters and MEC in asymptomatic AS.
Methods
Study population
Fifty-five consecutive patients with asymptomatic moderate to severe
AS who were able to perform a treadmill CPET were prospectively in-
cluded in the present study. Exclusion criteria: (i) more than mild aortic
or mitral regurgitation at echocardiography, (ii) abnormal cardiac
rhythm, (iii) paced rhythm, (iv) dilated or hypertrophic obstructive car-
diomyopathy, (v) known ischaemic heart disease, (vi) LVEF ,50%, (vii)
primary pulmonary hypertension, (viii) evidence of more than mild pul-
monary disease, and (ix) inadequate acoustic windows. For the CPET,
the absolute exclusion criteria specified by ATS/ACCP Statement on
Cardiopulmonary Testing were applied.12 All patients gave their con-
sent and the local ethics committee approved the protocol.
Echocardiographic measurements
Echocardiographic examination was performed using a Vivid ultrasound
(7 or E9) System (GE Healthcare, Little Chalfont, UK). All data were
stored in a digital format, which enabled subsequent off-line analysis
using dedicated software (EchoPAC, GE Vingmed Ultrasound AS, Hor-
ten, Norway). Eleven patients were excluded from the analysis because
of poor acoustic windows that made comprehensive LV function assess-
ment by STE impossible. The final cohort was composed of the remain-
ing 44 patients.
Evaluation of AS severity
Continuous wave Doppler was used to measure trans-aortic velocities.
Peak and mean trans-aortic pressure gradients were calculated using the
simplified Bernoulli equation (DP ¼ 4v2, where v is maximal aortic vel-
ocity in m/s). Aortic valve area (AVA) was calculated using the continuity
equation. AS was considered severe if the valve area was ,1 cm2.
Indexed AVA was obtained by dividing the AVA by the body surface area.
Evaluation of LV geometry, LV systolic, and diastolic
function using conventional resting echocardiography
The LV mass was calculated from the parasternal long-axis 2D greyscale
images using the formula of the European Association of Cardiovascular
Imaging and the American Society of Echocardiography.15 The LVEF,
end-systolic, and end-diastolic volumes were measured by Simpson’s bi-
plane method. The LV stroke volume was calculated by multiplying the
LV outflow tract area to LV outflow tract velocity time integral mea-
sured by pulse wave Doppler. Stroke volume was indexed to body sur-
face area. The LV cardiac output was calculated as the product of heart
rate and stroke volume. Peak mitral E- and A-wave velocities were mea-
sured using pulsed-wave Doppler. Peak early diastolic mitral annular vel-
ocities both at medial and lateral mitral annulus sites were measured
using tissue Doppler imaging in apical 4-chamber view and their values
were averaged (e′). The E/e′ ratio was then calculated.
Assessment of LV deformation parameters
LV longitudinal strain (LS), radial strain (RS), and circumferential strain
(CS) quantifications were performed using commercially available soft-
ware (EchoPAC version 112; GE Healthcare, Norway). Standard 2D
greyscale images, focused on the LV, were acquired in conventional ap-
ical 4-chamber, 2-chamber, and long-axis views, and in parasternal
short-axis view at the level of the papillary muscles. Care was taken
to obtain good endocardial border delineation, avoid artefacts and LV
chamber foreshortening and acquire loops with at least 60 frames per
second. With off-line analysis, the regions of interest were manually de-
fined by marking endocardial border at end-systole by the
point-and-click approach. The automatic tracking of the endocardial
contour was verified carefully, and the region of interest was manually
corrected to ensure optimal tracking of each myocardial segment
throughout systole and diastole. Any segment with inadequate tracking
was excluded from the final analysis. Peak segmental LS, CS, and RS ana-
lysis was performed by dividing the LV into six segments in each of the
obtained views. An average value for each myocardial region (basal, mid,
and apical) was provided for LV LS (bLS, mLS, and aLS, respectively). CS
and RS were also obtained after averaging peak segmental strain values.
If more than two segments in the short-axis view were not adequately
tracked, the average values of RS and CS were not reported, as more
than half of the myocardial segments were not available for analysis. Re-
producibility, as well as both inter-observer and intra-observer variabil-
ity of the LV strain analysis by speckle tracking in our laboratory were
already reported elsewhere.16 In our study, 75% (590/792) of the myo-
cardial segments for LS were adequately tracked. For CS and RS strain,
only 55% (145/264) were analysable.
Cardiopulmonary exercise testing
All patients underwent a multistage symptom-limited treadmill CPET.
A modified Bruce protocol was used with three distinct stages: a
warm up stage, an exercise stage with a progressive increase in work-
load, and a recovery stage. Patients were encouraged to exercise until
exhaustion, and discouraged from grasping and leaning on the handrails.
Blood pressure values were carefully monitored at the end of each stage
of the protocol using a calibrated sphygmomanometer, and continuous
12-lead electrocardiogram monitoring was recorded. Patient’s medica-
tions were not stopped for the test. A cardiologist monitored closely
the patient during the test and carefully searched for symptom develop-
ment or signs of abnormal test: angina, dizziness, sustained ventricular
arrhythmias, drop or inadequate rise (,20 mmHg) in systolic blood
pressure, or ≥2 mm ST segment depression 80 ms after the J point.
The test was promptly stopped in case of symptom occurrence. Peak
oxygen consumption (peak VO2) was measured. Device calibration
was performed before each test. Each CPET was performed within 1
month following echocardiographic examination.
Statistical analysis
Patients were divided into two groups according to the median value of
the peak VO2 distribution. The results were expressed as mean+
standard deviation or percentages unless otherwise specified. The stat-
istical differences between groups were assessed using a Student’s t-test,
x2 test, or Fisher’s exact test, as appropriate. The relationship between
echocardiographic data and peak VO2 was evaluated using a linear
regression model. To identify the independent predictors of exercise
capacity, we used multiple linear regression analysis. Only variables
associated with peak VO2 in univariable analysis were included in the
model and were carefully chosen in order to avoid colinearity. Receiver
operating characteristic (ROC) analysis was used to estimate cut-off
values of strain parameters able to predict reduced MEC. Values of
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P, 0.05 were considered significant. All the statistical analyses were
performed with SPSS version 17.0 (SPSS Inc., Chicago, IL, USA).
Results
Characteristics of the population
Among the 44 patients included in the study (age 66+ 13 years,
75% men), 29 (66%) had severe AS. None of the patients had known
peripheral artery disease or intermittent claudication during tread-
mill exercise. Patients’ clinical and demographic characteristics and
main CPET data are summarized in Table 1. The echocardiographic
characteristics of the studied population are depicted in Table 2.
Functional capacity in AS
Absolute peak VO2 was 20.1+5.8 mL/kg/min (median 20.7 mL/kg/
min; range 7.2–32.3 mL/kg/min, Figure 1). Twelve patients (27%) had
peak VO2, 84% of predicted values for age and sex. Of note, none
of them developed symptoms during the test. Patients with reduced
MEC (peak VO2, median) were significantly older, more frequent-
ly females (Table 1) and had lower LV end-diastolic and end-systolic
volumes, LV stroke volume and cardiac output, and higher E/e′ ratio
(Table 2). There were no other significant differences between the
two groups regarding clinical, demographic, and conventional echo-
cardiographic data (Tables 1 and 2).
There was a significant correlation between absolute peak VO2
and age (r ¼ 20.44), LV end-diastolic volume (r ¼ 0.35), LV stroke
volume (r ¼ 0.37), indexed stroke volume (r ¼ 0.32), and E/e′ ratio
(r ¼ 20.37) (Table 4). In contrast, there was no significant correl-
ation between peak VO2 and LVEF or any parameters of AS severity
(Table 4).
Relationship between LV myocardial
deformation parameters and functional
capacity
Among LV myocardial deformation parameters, bLS and mLS
were significantly associated with peakVO2 (r ¼ 0.43, P ¼ 0.005,
and r ¼ 0.32, P ¼ 0.04, respectively, Figure 2A and B). Patients with
reduced MEC had also lower bLS values compared with those with
preserved MEC (213.53+ 3.84 vs. 216.62+ 3.68%, P ¼ 0.01,
Table 3). However, aLS, CS, and RS were statistically similar between
patients with low and high MEC groups (all P ¼ NS, Table 3,
Figure 2C and Figure 3). There was a trend for lower mLS in patients
with reduced MEC (P ¼ 0.09, Table 3). Among all regional LV systol-
ic function parameters derived by speckle tracking, the strongest
univariable determinant of peak VO2 was bLS (Table 4). In multivari-
able analysis, in the model including age, LV stroke volume, E/e′ ratio,
and mLS, the main determinants of peak VO2 (r
2 ¼ 0.39) were fe-
male gender (b¼ 5.09, SE¼ 1.9, P¼ 0.01) and bLS (b¼ 0.86, SE¼
0.42, P¼ 0.046, Table 5).
Taken separately, when only one of the regional LV systolic func-
tion parameters derived by speckle tracking was included in the
model (i.e. either bLS or mLS), only bLS was identified as a deter-
minant of peak VO2 (r
2 ¼ 0.42, Table 6). In a similar model, mLS
failed to predict peak VO2 (b ¼ 0.24, SE ¼ 0.23, P ¼ 0.30) and
only female gender remained a predictor of peak VO2 (b ¼ 4.59,
SE ¼ 1.99, P ¼ 0.03, total r2 ¼ 0.39).
Using ROC curve analysis, the best cut-off values of bLS to predict
reduced MEC were215.3%, with a sensitivity and specificity of 70 and
68%, respectively [area under the curve (AUC) ¼ 0.71, P ¼ 0.02].
Of note, mLS was not accurate to discriminate between patients
with preserved MEC and reduced MEC (AUC ¼ 0.61, P ¼ 0.09).
Discussion
The major findings of the present study are (i) MEC varies widely in
asymptomatic patients with moderate to severe AS and is often low-
er than expected; about one-third of the study population had peak
VO2 lower than age, gender, and level of training-predicted values,
(ii) classical parameters of AS severity do not influence MEC,
(iii) MEC is modestly related to the degree of LV diastolic dysfunc-
tion and to LV end-diastolic volume, (iv) the only classical echocar-
diographic parameter of LV systolic function related to MEC is LV
stroke volume, (v) LVEF does not affect MEC in AS patients with
apparently preserved LV systolic function, and (vi) LV longitudinal
function of the basal myocardial segments is an important determin-
ant of MEC; a cut-off value of 215.3% could be used to predict
reduced MEC in asymptomatic patient with moderate to severe AS.
Functional capacity in AS
Several small studies have shown that exercise capacity is frequently
altered in patients with AS.13,17,18 In a study by Clyne et al.,13 asymp-
tomatic patients with AS had a reduced exercise tolerance when
compared with controls. Moreover, Rajani et al.18 showed that
peak indexed LV stroke volumes and peak VO2 values were lower
in patients who developed symptoms during the test. In the present
study, peak VO2 varied widely from normal to markedly reduced va-
lues (mean: 20.1+ 5.8 mL/kg/min). Peak VO2 values were signifi-
cantly lower in older patients and in females with asymptomatic
AS, in agreement with data obtained in the general population.12
It is worth emphasizing that the present study included only patients
without history of self-reported exertional dyspnoea, angina, or syn-
cope, and no symptom development during the treadmill exercise
test. Yet, one-third of the included patients had a lower than ex-
pected MEC for their age, gender, and level of training. Thus,
MEC as assessed by CPET, may be used as a clinical tool to ascertain
whether patients with AS are truly asymptomatic.
LVEF, diastolic function, and functional
capacity in AS
Peak VO2 is related to peak exercise cardiac output through the Fick
equation. Cardiac output is related to heart rate and stroke volume,
both at rest and during exercise. In our cohort, resting LV stroke
volume was associated with peak VO2, patients with lower MEC
had smaller LV stroke volume, suggesting that an LV with a low
stroke volume at rest does not have sufficient resources to adapt
to exercise. Hence, these patients with lower LV stroke volumes
at rest tend to have reduced MEC. Moreover, LV geometry seems
to be related to MEC in AS patients. Despite the fact that LV mass
and indexed mass were similar between groups, LVs with higher
end-diastolic volumes appeared to adapt better during exercise
(higher end-diastolic volume was associated with better MEC).
These results can suggest that loss of ‘LV filling volume’ related to
Left ventricular regional function Page 3 of 8
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Table 1 Demographic, clinical, and cardiopulmonary test data
Variable Overall (n 5 44) Preserved MEC (n5 22) Reduced MEC (n5 22) P
Clinical and demographic data
Age, years 66+13 60+12 73+10 ,0.001
Female gender, n (%) 11 (25) 3 (14) 8 (36) 0.05
Body mass index (kg/m2) 26+4 26+3 26+4 0.87
Heart rate (bpm) 78+10 79+9 79+11 0.80
SBP (mmHg) 132+19 131+16 133+23 0.85
DBP (mmHg) 72+9 74+9 70+8 0.11
Pulse pressure (mmHg) 60+17 58+15 63+19 0.31
Risk factors
Diabetes mellitus, n (%) 6 (14) 3 (14) 3 (14) 0.90
Active smoking, n (%) 9 (20) 7 (32) 2 (9) 0.09
Dyslipidaemia, n (%) 25 (57) 11 (50) 14 (64) 0.2
Hypertension, n (%) 28 (64) 13 (59) 15 (68) 0.3
Mild renal failure, n (%) 1 (2.3) 0 (0) 1 (100) 0.3
Cardiopulmonary test data
Test duration (min) 10+4 12+3 9+4 0.01
Workload (W) 110+38 129+29 90+35 0.001
Peak heart rate (bpm) 130+16 135+13 124+17 0.02
Peak SBP (mmHg) 161+23 163+24 158+23 0.49
Peak DBP (mmHg) 78+12 81+12 75+12 0.15
PCP (mmHg × mL/kg/min) 3195+1038 3919+722 2436+730 ,0.001
O2 pulse (mL/beat) 15+21 20+29 10+4 0.13
Data are presented as mean+ SD or n (%).
MEC, maximal exercise capacity; SBP, systolic blood pressure; DBP, diastolic blood pressure; PCP, peak circulatory power; O2 pulse, oxygen pulse.
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Table 2 Resting echocardiographic data
Variable Overall (n 5 44) Preserved MEC (n5 22) Reduced MEC (n5 22) P
LV geometry
LV end-diastolic volume (mL) 93+31 106+34 78+19 0.002
LV end-systolic volume (mL) 36+14 41+16 31+10 0.02
LV mass (g) 236+91 233+93 240+91 0.83
Indexed LV mass (g/m2) 129+47 117+32 143+59 0.09
LV function
Stroke volume (mL) 85+24 96+27 73+14 0.001
Indexed stroke volume (mL/m2) 46+10 50+10 42+8 0.009
Cardiac output (mL/min) 5.8+1.7 6.4+1.9 5.1+1.3 0.01
Cardiac index (mL/min/m2) 3.1+0.7 3.3+0.7 2.9+0.6 0.06
LVEF (%) 62+6 62+5 62+7 0.86
E/e′ 10+4 9+2 12+5 0.03
Aortic stenosis severity
Peak gradient (mmHg) 68+22 67+21 68+24 0.84
Mean gradient (mmHg) 41+15 40+14 41+15 0.89
Aortic valve area (cm2) 0.92+0.31 0.99+0.28 0.83+0.32 0.09
Indexed aortic valve area (cm2/m2) 0.49+0.16 0.51+0.14 0.47+0.18 0.35
Data are presented as mean+ SD.
MEC, maximal exercise capacity; LV, left ventricle; LVEF, left ventricle ejection fraction; E, peak early diastolic flow velocity measured at the mitral leaflets tip; e′ , mitral annulus peak
early diastolic velocity.
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concentric remodelling/hypertrophy can be deleterious on MEC in
AS. To note, a large proportion (81%) of our patients had LV con-
centric hypertrophy or concentric remodelling.
Interestingly, from all conventional parameters of LV systolic
function, only LV stroke volume showed a significant relationship
with peak VO2, while LVEF was neither associated with lower
MEC, nor different between groups. The lack of association
between LVEF and peak VO2 suggests that LVEF is a poor estimator
of LV systolic performance in patients with concentric remodelling
and increased LV haemodynamic afterload. In univariable analysis,
reduced exercise capacity was also associated with an impaired
LV diastolic function, as assessed by the E/e′ ratio—a surrogate of
LV filling pressure. Patients with higher E/e′ ratio at rest had a worse
adaptation to exercise, as measured by peak VO2 values, suggesting
that resting diastolic dysfunction can also have a negative impact on
MEC. Our data are in line with previous studies that showed that
diastolic dysfunction influences MEC.19–21
LV longitudinal function and functional
capacity in AS
In the current guidelines, LVEF is the only LV function parameter
used to recommend AVR in asymptomatic patients with severe
AS.1 However, there is unquestionable evidence that LVEF can
be misleading in the assessment of LV systolic performance in
AS.22 – 24 In AS, the presence of LV hypertrophy, through a
simple geometrical effect, can generate a confusing impression of
‘normal’ LV systolic performance, despite a progressive decline in
LV contractility. In contrast, as highlighted in previous studies,6,25–27
LV longitudinal systolic function is impaired earlier in conditions
Figure 1 MEC in patients with AS.
Figure 2 Relationship between MEC (Peak VO2) and basal (A), mid (B) and apical strains, as assessed by STE (C).
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with high afterload, as in AS. Global LV longitudinal shortening
is more closely associated with changes in symptomatic status,
abnormal exercise response, and outcome than LVEF in
asymptomatic AS.10,11,28
This study shows, for the first time to our knowledge, that LV
longitudinal systolic function represents a major determinant of
MEC in asymptomatic AS; longitudinal function in the basal, but
not in the mid and apical myocardial segments being a predictor
of MEC. The base-to-apex gradient in LS described in AS was
more pronounced in patients with reduced MEC.10,11,25,29,30 LS
was significantly lower in the basal segments compared with the
apex. It is well known that longitudinal function is governed by
the subendocardial myocardial fibres, which are more likely to
be affected by microvascular ischaemia. However, basal segments,
due to their higher systolic wall stress, are even more susceptible
to elicit early systolic dysfunction than the mid and apical seg-
ments.11,31,32 This could explain why GLS, averaging base-to-apex
strains, weakly predicted reduced MEC in our population. Reduced
bLS has emerged in a few studies as an important determinant of
low-flow state, poor LV adaptation to exercise, and global cardiac
events in AS.29,30 bLS has also been constantly found to be a more
powerful predictor of outcome than GLS, suggesting that it could
be a more sensitive marker of LV dysfunction. Recent cardiac mag-
netic resonance studies have shown that myocardial fibrosis is pre-
dominantly found in the basal segments of the LV, which can
contribute to impaired bLS.7 After AVR, the recovery of longitu-
dinal function may still occur but it mainly results from improve-
ment of the basal and mid segmental function.33 Although
reduced bLS is a marker of limited MEC, it may identify a subgroup
of patients with less advanced disease process. It may thus precede
the diffuse alteration in intrinsic myocardial function, which is often
associated with a more significant decrease in GLS and diffuse
myocardial fibrosis.7 Whether bLS could be used to optimize
the timing of AVR needs to be addressed in a larger series of
patients.
The fact that this difference was particularly evidenced on LS, and
absent in its radial and circumferential component, probably reflects
the earlier impairment of longitudinal function in these patients.30 In
addition, the better intra-observer and inter-observer reproducibility
reported for LS when compared with RS and CS could also have
contributed to this observation.9
Limitations
The sample size of the present study is relatively small but all
patients included had a CPET. Diabetes and hypertension may influ-
ence strain values; however, there were no significant differences in
these parameters between groups. Peak VO2 may also be affected
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Table 3 LV myocardial deformation parameters
Variable Overall (n 5 44) Preserved MEC (n 5 22) Reduced MEC (n 5 22) P
LV function (deformation imaging derived parameters)
Average basal longitudinal strain (%) 15.2+4 16.7+3.7 13.5+3.8 0.01
Average mid longitudinal strain (%) 19+4.1 20+3.3 17.9+4.7 0.09
Average apical longitudinal strain (%) 23.4+4.7 23.7+4.4 23.1+5.2 0.68
Average circumferential strain (%) 20+4 20+2.9 19.9+5.5 0.94
Average radial strain (%) 51.1+24.4 55.9+24.3 42.2+23.7 0.21
Data are presented as mean+ SD.
MEC, maximal exercise capacity; LV, left ventricle; LVEF, left ventricular ejection fraction.
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LV end-diastolic volume 0.35 0.02
LV end-systolic volume 0.26 0.10
LV mass 0.04 0.79
Indexed LV mass 20.11 0.52
LV systolic function
LV stroke volume 0.37 0.02
Indexed LV stroke volume 0.32 0.04
Cardiac output 0.25 0.11
Cardiac index 0.19 0.24
LVEF 0.04 0.81
Average basal longitudinal strain 0.43 0.005
Average mid longitudinal strain 0.32 0.04
Average apical longitudinal strain 0.13 0.40
Average circumferential strain 0.11 0.61
Average radial strain 0.24 0.28
LV diastolic function
E/A ratio 20.12 0.48
E/e′ ratio 20.37 0.02
AS severity
Peak aortic pressure gradient 0.02 0.88
Mean aortic pressure gradient 20.01 0.97
Aortic valve area 0.23 0.13
Indexed aortic valve area 0.15 0.32
LV, left ventricle; LVEF, left ventricle ejection fraction; E, peak early diastolic flow
velocity measured at the mitral leaflets tip; A, peak late diastolic flow velocity
measured at the mitral leaflets tips; e′ , mitral annulus peak early diastolic velocity.
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by pulmonary diseases, neuromuscular, or musculoskeletal disease,
anaemia or any other pathology that decreases the oxygen trans-
port capacity of blood. However, none of the patients included in
the present study had symptoms or any of the above-mentioned
pathologies. Exercise-induced myocardial ischaemia may be a limit-
ing factor of MEC. However, none of our patients had a history of
coronary artery disease, or presented angina or significant ST
changes suggestive of active myocardial ischaemia during exercise.
Conclusion
In asymptomatic patients with moderate to severe AS and pre-
served LVEF, LV myocardial longitudinal function is the main deter-
minant of reduced MEC. bLS was the only parameter of LV regional
function, as assessed by STE, independently associated with MEC.
Further studies are needed to explore the potential role of MEC
and LV longitudinal systolic dysfunction in the risk stratification of
asymptomatic AS.
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